Almanack Investment Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $259K | Buy |
2,154
+141
| +7% | +$16.3K | 0.04% | 146 |
|
|
2025
Q4 | $212K | Sell |
2,013
-1,001
| -33% | -$94K | 0.04% | 158 |
|
|
2025
Q3 | $253K | Sell |
3,014
-15,335
| -84% | -$1.26M | 0.04% | 168 |
|
|
2025
Q2 | $1.45M | Buy |
18,349
+14,276
| +351% | +$1.13M | 0.23% | 67 |
|
|
2025
Q1 | $366K | Buy |
4,073
+832
| +26% | +$77.7K | 0.07% | 108 |
|
|
2024
Q4 | $322K | Buy |
3,241
+141
| +5% | +$14.5K | 0.05% | 136 |
|
|
2024
Q3 | $352K | Sell |
3,100
-381
| -11% | -$45.3K | 0.06% | 133 |
|
|
2024
Q2 | $431K | Buy |
3,481
+52
| +2% | +$6.7K | 0.07% | 114 |
|
|
2024
Q1 | $452K | Buy |
3,429
+239
| +7% | +$29.5K | 0.08% | 110 |
|
|
2023
Q4 | $348K | Buy |
3,190
+136
| +4% | +$14.1K | 0.06% | 112 |
|
|
2023
Q3 | $314K | Sell |
3,054
-1,510
| -33% | -$163K | 0.06% | 108 |
|
|
2023
Q2 | $527K | Sell |
4,564
-66
| -1% | -$7.49K | 0.09% | 91 |
|
|
2023
Q1 | $493K | Sell |
4,630
-100
| -2% | -$10.8K | 0.1% | 88 |
|
|
2022
Q4 | $525K | Sell |
4,730
-7,096
| -60% | -$725K | 0.11% | 80 |
|
|
2022
Q3 | $1.02M | Buy |
11,826
+3,390
| +40% | +$303K | 0.2% | 52 |
|
|
2022
Q2 | $775K | Buy |
8,436
+54
| +0.6% | +$4.79K | 0.08% | 164 |
|
|
2022
Q1 | $694K | Buy |
8,382
+825
| +11% | +$65K | 0.06% | 207 |
|
|
2021
Q4 | $584K | Sell |
7,557
-1,214
| -14% | -$96.7K | 0.05% | 232 |
|
|
2021
Q3 | $664K | Buy |
8,771
+1,411
| +19% | +$107K | 0.06% | 203 |
|
|
2021
Q2 | $577K | Sell |
7,360
-1,528
| -17% | -$114K | 0.06% | 203 |
|
|
2021
Q1 | $659K | Buy |
8,888
+607
| +7% | +$44.8K | 0.07% | 188 |
|
|
2020
Q4 | $651K | Buy |
8,281
+2,715
| +49% | +$208K | 0.07% | 168 |
|
|
2020
Q3 | $431K | Buy |
5,566
+1,216
| +28% | +$95.2K | 0.05% | 233 |
|
|
2020
Q2 | $324K | Sell |
4,350
-37
| -0.8% | -$2.79K | 0.06% | 175 |
|
|
2020
Q1 | $324K | Buy |
+4,387
| New | +$345K | 0.07% | 171 |
|
|
2019
Q4 | – | Sell |
-3,927
| Closed | -$317K | – | 216 |
|
|
2019
Q3 | $317K | Sell |
3,927
-65
| -2% | -$5.21K | 0.06% | 153 |
|
|
2019
Q2 | $321K | Buy |
+3,992
| New | +$306K | 0.07% | 131 |
|
|
2019
Q1 | – | Sell |
-1,794
| Closed | -$132K | – | 182 |
|
|
2018
Q4 | $132K | Sell |
1,794
-143
| -7% | -$10.1K | 0.04% | 197 |
|
|
2018
Q3 | $139K | Buy |
+1,937
| New | +$123K | 0.04% | 222 |
|
Other funds holding MRK
VCM
VPM
Almanack Investment Partners's MRK Position: Q1 2026 in Review
Almanack Investment Partners increased its Merck (MRK) stake by 7% in Q1 2026, buying an estimated $16.3K and bringing the position to 2,154 shares worth $259K. The position accounts for 0.04% of the portfolio, ranked #146.
Almanack Investment Partners first reported a position in MRK in Q3 2018 and has held it in 29 quarters since. The position peaked at $1.45M in Q2 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Almanack Investment Partners held 2,154 shares of Merck worth $259K as of Q1 2026.
- Almanack Investment Partners bought 141 Merck shares in Q1 2026, an estimated $16.3K.
- Merck made up 0.04% of Almanack Investment Partners's portfolio in Q1 2026, its #146 holding.
- Almanack Investment Partners first reported a position in Merck in Q3 2018 and has held it in 29 quarters since.
- Almanack Investment Partners's Merck position peaked at $1.45M in Q2 2025.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Almanack Investment Partners's 13F filing for Q1 2026, filed 5 May 2026.